Skip to main content
. 2013 May 14;122(4):491–498. doi: 10.1182/blood-2013-02-453175

Table 1.

Selected series comparing myeloablative single unit UCBT with transplantation of adult donors in adults

Series Patients, n Conditioning Graft source Median Age (years) DFS, % Comment
Takahashi, Blood 2007,95 hematologic malignancy 71 UCB 38 70 UCB similar or superior to matched sibling donor transplant
55 BM Myelo MRD 40 60
6 PBSC Ablative
Atsuta, Blood 2009,96 acute leukemia 287 UCB
173 AML Myelo 38 42
114 ALL Ablative 34 46 UCB similar to MUD in ALL
533 MUD UCB inferior in AML (higher TRM)
311 AML 38 54
222 ALL 32 44
Eapen, Lancet 2010,65 acute leukemia 165 UCB 28 44 UCB and MUD comparable; disease status only factor associated with DFS
888 Myelo PBSC 39 50
623 Ablative MUD
265 MMUD
472 BM 33 52
332 MUD
140 MMUD

ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; PBSC, peripheral blood stem cell.